Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 23110868)

1.

The influence of insulin infusion on the metabolism of amyloid β peptides in plasma.

Karczewska-Kupczewska M, Lelental N, Adamska A, Nikołajuk A, Kowalska I, Górska M, Zimmermann R, Kornhuber J, Strączkowski M, Lewczuk P.

Alzheimers Dement. 2013 Jul;9(4):400-5. doi: 10.1016/j.jalz.2012.01.013. Epub 2012 Oct 27.

PMID:
23110868
2.

Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling.

Høeg LD, Sjøberg KA, Jeppesen J, Jensen TE, Frøsig C, Birk JB, Bisiani B, Hiscock N, Pilegaard H, Wojtaszewski JF, Richter EA, Kiens B.

Diabetes. 2011 Jan;60(1):64-73. doi: 10.2337/db10-0698. Epub 2010 Oct 18.

3.

Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fat meal in young healthy male subjects.

Karczewska-Kupczewska M, Kowalska I, Nikołajuk A, Adamska A, Zielińska M, Kamińska N, Otziomek E, Górska M, Strączkowski M.

Diabetes Care. 2012 Feb;35(2):358-62. doi: 10.2337/dc11-1295. Epub 2011 Dec 30.

4.

Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

Diabetes. 2002 Oct;51(10):3043-8.

5.

The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and β-cell dysfunction in overweight and obese nondiabetic men.

Xiao C, Giacca A, Lewis GF.

Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1205-11. doi: 10.1152/ajpendo.00313.2009. Epub 2009 Sep 15.

6.
7.

Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans.

Hunter SJ, Boyd AC, O'Harte FP, McKillop AM, Wiggam MI, Mooney MH, McCluskey JT, Lindsay JR, Ennis CN, Gamble R, Sheridan B, Barnett CR, McNulty H, Bell PM, Flatt PR.

Diabetes. 2003 Feb;52(2):492-8.

8.

Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans.

Chai W, Liu J, Jahn LA, Fowler DE, Barrett EJ, Liu Z.

Diabetes Care. 2011 Jul;34(7):1634-8. doi: 10.2337/dc10-2345. Epub 2011 May 26.

9.

Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes.

Storgaard H, Jensen CB, Vaag AA, Vølund A, Madsbad S.

Metabolism. 2003 Jul;52(7):885-94.

PMID:
12870166
10.

Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype.

Zimmermann R, Huber E, Schamber C, Lelental N, Mroczko B, Brandner S, Maler JM, Oberstein T, Szmitkowski M, Rauh M, Kornhuber J, Lewczuk P.

J Alzheimers Dis. 2014;40(4):1055-60. doi: 10.3233/JAD-132687.

PMID:
24577473
11.

The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.

Fei M, Jianghua W, Rujuan M, Wei Z, Qian W.

J Neurol Sci. 2011 Jun 15;305(1-2):92-6. doi: 10.1016/j.jns.2011.03.005. Epub 2011 Mar 26.

PMID:
21440911
12.

Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.

Mostad IL, Bjerve KS, Basu S, Sutton P, Frayn KN, Grill V.

Metabolism. 2009 Dec;58(12):1753-61. doi: 10.1016/j.metabol.2009.06.003. Epub 2009 Aug 27.

PMID:
19716144
13.

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

Diabetes. 2003 Oct;52(10):2461-74.

14.

Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

Diabetes Care. 1993 Oct;16(10):1347-55.

PMID:
8269792
15.

Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.

Nogueira JP, Maraninchi M, Béliard S, Padilla N, Duvillard L, Mancini J, Nicolay A, Xiao C, Vialettes B, Lewis GF, Valéro R.

Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):1039-44. doi: 10.1161/ATVBAHA.111.242073. Epub 2012 Feb 2.

16.
17.

Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.

Nauck MA, Weber I, Bach I, Richter S, Orskov C, Holst JJ, Schmiegel W.

Diabet Med. 1998 Nov;15(11):937-45.

PMID:
9827848
18.

Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease.

Kulstad JJ, Green PS, Cook DG, Watson GS, Reger MA, Baker LD, Plymate SR, Asthana S, Rhoads K, Mehta PD, Craft S.

Neurology. 2006 May 23;66(10):1506-10.

PMID:
16717209
19.

Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study.

Townsend MK, Okereke OI, Xia W, Yang T, Selkoe DJ, Grodstein F.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):50-4. doi: 10.1097/WAD.0b013e31821764ce.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk